Promosyon programı Jacobio Pharmaceuticals Group Co., Ltd.
Şirket hakkında Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd., фармацевтическая компания клинической стадии, специализирующаяся на собственных открытиях и разработках методов лечения онкологических заболеваний. daha fazla ayrıntı| ISIN | KYG4987A1094 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | hkd |
| Валюта отчета | cny |
| Сайт | https://www.jacobiopharma.com |
| Цена ао | 3.35 |
| Günlük fiyat değişimi: | +16.32% (2.88) |
|---|---|
| Haftalık fiyat değişimi: | +25.47% (2.67) |
| Aylık fiyat değişimi: | +114.74% (1.56) |
| 3 ayda fiyat değişimi: | +153.79% (1.32) |
| Altı ayda fiyat değişimi: | +98.22% (1.69) |
| Yıllık fiyat değişimi: | +81.08% (1.85) |
| 3 yılda fiyat değişimi: | -51.31% (6.88) |
| Yılbaşından bu yana fiyat değişimi: | +172.36% (1.23) |
|
|
Hafife alma
|
Yeterlik
|
|||||||||||||||||||||||||||||||||||||
Temettüler
|
Görev
|
Büyüme dürtüsü
|
|||||||||||||||||||||||||||||||||||||
| Kurumlar | Hacim | Paylaşmak, % |
|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 5537100 | 0.7 |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 2918512 | 0.37 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 1458600 | 0.18 |
| Schwab Strategic Tr-Schwab International Small Cap Equity ETF | 738959 | 0.09 |
| DFA Emerging Markets Small Cap Series | 514800 | 0.07 |
| Vanguard International Stock Index-Pacific Stock Index | 444900 | 0.06 |
| Vanguard Intl Equity Index - Total World Stock Index Fd | 318600 | 0.04 |
| SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF | 274990 | 0.03 |
| iShares MSCI China Small Cap ETF | 198000 | 0.03 |
| College Retirement Equities Fund-Stock Account | 163500 | 0.02 |
| ETF | Paylaşmak, % | Yıllık karlılık, % | Temettüler, % |
|---|---|---|---|
SPDR S&P China ETF
|
0.0019 | 17.02 | 3.40103 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0 | 9.39 | 3.09932 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| 0.00000 | 10.93 | 3.19 |
| Süpervizör | İş unvanı | Ödeme | Doğum yılı |
|---|---|---|---|
| Dr. Yinxiang Wang | Executive Chairman & CEO | 3.19M | 1965 (60 yıllar) |
| Ms. Xiaojie Wang | Executive Director & President of Administration | 2.43M | 1965 (60 yıllar) |
| Ms. Yunyan Hu | Executive VP & Executive Director | 2.57M | 1962 (63 yıl) |
| Dr. Andrea Wang-Gillam M.D., Ph.D. | Executive VP, Chief Medical Officer and Global Head of R&D | N/A | 1971 (54 yıl) |
| Ms. Qing Xue | Joint Company Secretary | N/A | 1989 (36 yıllar) |
| Ms. Tao Yang | Vice President of Human Resources | N/A | |
| Ms. Yanping Wang | Executive Vice President of Non-Clinical R&D | N/A | |
| Dr. Haijun Wang | Senior Vice President of Information & Data Management | N/A | |
| Ms. Yuli Ding | Executive Vice President of Clinical Development | N/A | |
| Mr. Ming Fai Chung CPA | Joint Company Secretary | 1979 (46 yıllar) |
Adres: China, Beijing, Building 8 - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.jacobiopharma.com
Web sitesi: https://www.jacobiopharma.com
